Optic Nerve Glioma — Trials

Optic Nerve Glioma — Trials · CancerIndex

Clinical trials

Registered studies

9 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03326388	Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours(INSPECT)	completed	Phase 1 / Phase 2	14	Great Ormond Street Hospital for Children NHS Foundation TrustOTHER	1	Apr 4, 2024	clinicaltrials
NCT02839720	Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma	completed	Phase 2	11	National Cancer Institute (NCI)NIH	1	Dec 6, 2023	clinicaltrials
NCT01800032	PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)	completed	—	30	UNC Lineberger Comprehensive Cancer CenterOTHER	1	May 12, 2021	clinicaltrials

Data updated 22 days agoSource updated Apr 4, 2024source: clinicaltrials